Restricted accessLetterFirst published online 2021-08
Reply to Letter by Alexander Seibold on “Impact of Switching from Intermittently Scanned to Real-Time Continuous Glucose Monitoring Systems in a Type 1 Diabetes Patient French Cohort: An Observational Study of Clinical Practices” by Yannis Préau,et al. (doi: 10.1089/dia.2020.0674)
SeiboldA: Incongruent changes in lab HbA1c and average glucose underscore significant differences in calibration between continuous glucose monitoring systems during the conduct of a study on glycemic control in type 1 diabetes. Comment on Préau et al. Diabetes Technol Ther, 2021; 23:595–597.
2.
PréauY, ArmandM, GalieS, et al.: Impact of switching from intermittently scanned to real-time continuous glucose monitoring systems in a type 1 diabetes patient French cohort: an observational study of clinical practices. Diabetes Technol Ther, 2021; 23:259–267.
3.
ReachG: Decisions in the psychology of glucose monitoring. J Diabetes Sci Technol, 2019; 13:1169–1174.
4.
MineY, UrakamiT, MatsuuraD: Allergic contact dermatitis caused by isobornyl acrylate when using the Freestyle Libre. J Diabetes Investig, 2019; 10:1382–1384.
5.
DunnTC, XuY, HayterG, et al.: Real-world flash glucose monitoring patterns and associations between self-monitoring frequency and glycemic measures: a European analysis of over 60 million glucose tests. Diabetes Res Clin Pract, 2018; 137:37–46.
6.
RivelineJP, GuerciB, Wojtusciszyn, et al.: The frequency of FreeStyle Libre glucose sensor scans performed by the diabetic patient on a daily basis is associated with better parameters form monitoring his glucose profile: analysis of 312 million hours of monitoring in real life in France. Med Mal Metab, 2020; 14:585–593.
7.
KirchsteigerH, HeinemannL, FreckmannG, et al.: Performance comparison of CGM systems: MARD values are not always a reliable indicator of CGM system accuracy. J Diabetes Sci Technol, 2015; 9:1030–1040.
8.
ReddyM, OliverN: Reply to Letter by Seibold regarding Monika Reddy, Narvada Jugnee, Sinthuka Anantharaja, and Nick Oliver, Switching from Flash Glucose Monitoring to Continuous Glucose Monitoring on Hypoglycemia in Adults with Type 1 Diabetes at High Hypoglycemia Risk: the Extension Phase of the I HART CGM Study. Diabetes Technol Ther, 2019; 21:99–100.
9.
BattelinoT, DanneT, BergenstalRM, et al.: Clinical targets for continuous glucose monitoring data interpretation: recommendations from the international consensus on time in range. Diabetes Care, 2019; 42:1593–1603.
10.
ReddyM, JugneeN, AnantharajaS, OliverN: Switching from flash glucose monitoring to continuous glucose monitoring on hypoglycemia in adults with type 1 diabetes at high hypoglycemia risk: the extension phase of the I HART CGM study. Diabetes Technol Ther, 2018; 20:751–757.
11.
BeckRW, BergenstalRM, ChengP, et al.: The relationships between time in range, hyperglycemia metrics, and HbA1c. J Diabetes Sci Technol, 2019; 13:614–626.
12.
GallagherEJ, Le RoithD, BloomgardenZ: Review of haemoglobin A1c in the management of diabetes. J Diabetes, 2009; 1:9–17.
